Evofem Biosciences to Present at LD Micro Investor Conference on October 12, 2021

Rhea-AI Summary

Evofem Biosciences (NASDAQ: EVFM) announced its CEO, Saundra Pelletier, will present at the LD Micro Main Event in Los Angeles from October 12-14, 2021. The presentation is scheduled for October 12 at 12:30 p.m. PT. The company recently launched a new campaign, "House Rules," on September 9, 2021, to promote its hormone-free contraceptive, Phexxi. The campaign has successfully increased media coverage, site traffic, and telehealth visits, enhancing Phexxi prescription growth. Interested parties can register for the virtual presentation via the company website.

SAN DIEGO, Sept. 30, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief Executive Officer Saundra Pelletier will present and host one-on-one meetings at the 14^th annual LD Micro Main Event being held in Los Angeles on October 12-14, 2021.

Date:	Tuesday, October 12, 2021
Time:	12:30 p.m. PT (3:30 p.m. ET)
Location:	Luxe Sunset Bel Air (Los Angeles), Track 1

Evofem recently launched its new direct-to-consumer campaign "House Rules" focused on building awareness of its hormone-free contraceptive, Phexxi® (lactic acid, citric acid and potassium bitartrate), while empowering women to kiss hormonal contraception goodbye.

The campaign, which launched September 9, 2021, has garnered significant media coverage and is driving increased site sessions and telehealth visits on Phexxi.com and Phexxi prescription growth.

Register to watch the virtual presentation at https://me21.mysequire.com/ or through the Investors section of the company's website, under "Events & Presentations."

About Evofem Biosciences
Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first FDA-approved product, Phexxi, is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Learn more at phexxi.com and evofem.com.

Phexxi^® is a registered trademark of Evofem Biosciences, Inc.

Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/evofem-biosciences-to-present-at-ld-micro-investor-conference-on-october-12-2021-301388698.html

SOURCE Evofem Biosciences, Inc.

FAQ

When will Evofem Biosciences present at the LD Micro Main Event?

Evofem Biosciences will present at the LD Micro Main Event on October 12, 2021, at 12:30 p.m. PT.

What is the focus of the campaign launched by Evofem on September 9, 2021?

The campaign, called "House Rules," aims to promote awareness of Evofem's hormone-free contraceptive, Phexxi.

Where is the LD Micro Main Event taking place?

The LD Micro Main Event will be held at Luxe Sunset Bel Air in Los Angeles.

How has the "House Rules" campaign impacted Phexxi's prescription growth?

The campaign has significantly increased media coverage, site sessions, and telehealth visits, contributing to the growth of Phexxi prescriptions.

How can I watch the Evofem Biosciences presentation virtually?

You can register to watch the presentation at https://me21.mysequire.com/ or through the Investors section of Evofem's website.